AASTROM BIOSCIENCES, INC.

NASDAQ: ASTM
These are the top analyst upgrades, downgrades and initiations from select Wall Street research calls on Thursday, March 28, 2013. They include Lululemon, Nike, Under Armour and United Technologies.
Source: thinkstockHere are today’s five biggest gaining stocks at closing:Comstock Holding Companies Inc. (NASDAQ: CHCI) is up 59.8% at $1.87.Redhill Biopharma Ltd. (NASDAQ: RDHL) is up 41.3% at...
Source: ThinkstockAastrom Biosciences Inc. (NASDAQ: ASTM) has just joined in on the long list of biotech implosions. Perhaps the only thing that is so surprising after the fact, with a 35% price drop...
Markets opened higher this morning following a solid report on US retail sales. Reports on both consumer and small business confidence both showed improvement in February (more coverage here and...
US equities opened higher this morning following the report on a US non-farm payroll gain of 227,000 jobs (more coverage here). In Europe, the Greek debt swap deal went off smoothly, but the...
Shortly before noon ET today, all three major US stock indexes have posted gains, with the DJIA up about 41 points at around12,949, the Nasdaq up about 20 points at 2,991, and the S&P 500 up more...
Biotech and BioHealth stocks are on the move today and there is more news in the emerging sector than there has been on a single day in months and months.  The news is not even on any of the...
Stem cell stocks are getting hit pretty hard this Tuesday.  On Monday came a ruling from a U.S. district judge which effectively blocks the federal government from funding research which involves...
Stem cell stocks (tracked in Tickerspy’s Stem Cell Stock’s Index (*RXSTM) are up over 7% today, led by Athersys Inc (NASDAQ: ATHX).  Athersys Inc. rose as high as 395% this morning...
Tickerspy’s Stem Cell Stock Index (*RSXTM) took off today, rising nearly 13%.  The movement followed a release from the National Institutes of Health  (NIH) announcing that 13 embryonic stem...
General Electric Company (NYSE: GE) is taking a bold and controversial new step into the field of embryonic stem cell research.  The company has signed an exclusive license and alliance pact with...
We are seeing massive gap-ups this morning in stem cell stocks. President Obama is signing an executive order that will lift the Bush ban on funding of embryonic stem cell funding. What is...
Despite not knowing whom the ultimate winner of the 2008 Presidential election will be, it looks like stem cells may be one of the real bright spots as far as which area in biotech will be open for...
Stock Tickers: STEM, GERN, ASTM Senator Obama has issued a statement regarding President Bush’s veto of the Embryonic Stem Cell Bill: Senator Obama noted:  "By vetoing funding for...